CLOVER HEALTH INVESTMENTS CO (CLOV)

US18914F1030 - Common Stock

0.6741  -0.01 (-0.87%)

After market: 0.6717 0 (-0.36%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
1.472B3.477B
136.19%		2.034B
-41.50%		1.301B
-36.03%
EBITDA
YoY % growth
-635.75M-369.71M
41.85%		-180.157M
51.27%		-9.906M
94.50%		N/A
EBIT
YoY % growth
-637M
-9,131.88%		-370.9M
41.77%		-182.666M
50.75%		-149.395M
18.21%		N/A
Operating Margin
-43.27%-10.67%-8.98%-11.48%N/A
EPS
YoY % growth
-1.27-0.74
41.52%		-0.44
40.94%		-0.23
48.84%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.07
50.82%
Revenue
Q2Q % growth		327.65M
-37.92%
EBITDA
Q2Q % growth		-10.333M
EBIT
Q2Q % growth		-45.073M
37.92%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.14
20.00%		-0.140.001.49%
Q3 2023
Q2Q % growth		 -0.09
43.75%		-0.110.0216.50%
Q2 2023
Q2Q % growth		 -0.06
72.73%		-0.150.0960.89%
Q1 2023
Q2Q % growth		 -0.15
21.05%		-0.180.0316.35%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 510.251M
-43.23%		489.86M20.391M4.16%
Q3 2023
Q2Q % growth		 482.1M
-43.73%		504.49M-22.39M-4.44%
Q2 2023
Q2Q % growth		 513.6M
-39.34%		500.64M12.96M2.59%
Q1 2023
Q2Q % growth		 527.8M
-39.64%		508.71M19.09M3.75%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 3.98% -22.37% -15.94%
Revenue0% -25.85% -23.65% -24.45%